TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11006057

Group type: EXPERIMENTAL
Intervention: Health Belief Model (HBM) elements
Number of subjects: 3648

Group type: EXPERIMENTAL
Intervention: Demographic and health variables
Number of subjects: 3648
Study: 8852159

Group type: EXPERIMENTAL
Intervention: X-Prep with a less restrictive diet and one enema
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 140
Study: 1987708

Group type: EXPERIMENTAL
Intervention: Transfusion of cryopreserved donor-specific bone marrow
Number of subjects: 57

Group type: COMPARATOR
Intervention: Quadruple immunosuppression (MALG, cyclosporin, azathioprine, prednisone) with no marrow transfusion
Number of subjects: 57
Study: 6134180

Group type: EXPERIMENTAL
Intervention: Gradual withdrawal of diazepam over 3 months by stepwise reduction.
Number of subjects: 41

Group type: COMPARATOR
Intervention: Immediate withdrawal (double-blind procedure).
Number of subjects: 41

Group type: COMPARATOR
Intervention: Delayed withdrawal (after 8 weeks, double-blind procedure).
Number of subjects: 41
Study: 2870640

Group type: EXPERIMENTAL
Intervention: Buspirone
Number of subjects: 336

Group type: COMPARATOR
Intervention: Clorazepate
Number of subjects: 336
Study: 31594196

Group type: EXPERIMENTAL
Intervention: Whole-body cryotherapy at -110°C with exercise therapy
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Whole-body cryotherapy at -60°C with exercise therapy
Number of subjects: 92

Group type: COMPARATOR
Intervention: Exercise therapy alone
Number of subjects: 92
Study: 29609596

Group type: EXPERIMENTAL
Intervention: Traditional learning approach
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Blended learning approach
Number of subjects: 40
Study: 24534884

Group type: EXPERIMENTAL
Intervention: Regular consumption of pork (up to 1 kg/week)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Regular consumption of beef (up to 1 kg/week)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Regular consumption of chicken (up to 1 kg/week)
Number of subjects: 49
Study: 23321178

Group type: EXPERIMENTAL
Intervention: Transareola single‐site endoscopic thyroidectomy (TASSET)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Minimally invasive video‐assisted thyroidectomy (MIVAT)
Number of subjects: 48
Study: 20416951

Group type: EXPERIMENTAL
Intervention: Cataract extraction by phacoemulsification
Number of subjects: 6107

Group type: EXPERIMENTAL
Intervention: Preintervention VA and negative surgical complexity
Number of subjects: 6107

Group type: EXPERIMENTAL
Intervention: Preintervention visual function and expected postintervention VA
Number of subjects: 6107
Study: 17311054

Group type: EXPERIMENTAL
Intervention: Low GI diet
Number of subjects: 14

Group type: COMPARATOR
Intervention: High GI diet
Number of subjects: 14
Study: 15968892

Group type: EXPERIMENTAL
Intervention: tcPO2 measurement before amputation
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: tcPO2 values between 25 and 36 mm Hg
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: tcPO2 threshold value
Number of subjects: 56
Study: 12875346

Group type: EXPERIMENTAL
Intervention: Current oral suspension
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Former oral suspension
Number of subjects: 0
Study: 10505695

Group type: EXPERIMENTAL
Intervention: Eicosapentanoic acid (EPA) at a dose of 1800 mg daily for 3 months
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 7559196

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (200 mg bd iv)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Triple therapy (ceftazidime 1 g bd iv, ampicillin 500 mg qds iv, metronidazole 500 mg tds iv)
Number of subjects: 100
Study: 1771312

Group type: EXPERIMENTAL
Intervention: Desensitization by autologous saliva
Number of subjects: 44

Group type: COMPARATOR
Intervention: Physiological saline (Control)
Number of subjects: 44
Study: 7124839

Group type: EXPERIMENTAL
Intervention: Clindamycin-gentamicin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cefamandole-placebo
Number of subjects: 0
Study: 31970564

Group type: EXPERIMENTAL
Intervention: PBM therapy with a CW GaAIAs diode laser (808 nm; 0.028 mm2; 0.1 W; 3.6 W/cm2; 89 J/cm2; 2.5 J/point)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 20
Study: 30961357

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 0
Study: 29021311

Group type: EXPERIMENTAL
Intervention: Endovascular treatment arm (n=30)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Emergency endovascular treatment of the extracranial disease (n=17)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Staged carotid revascularization (n=4)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Cervical pseudo-occlusions (n=4)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Antithrombotic agents after acute carotid artery stenting
Number of subjects: 54

Group type: COMPARATOR
Intervention: Subjects with tandem occlusions
Number of subjects: 54
Study: 27418545

Group type: EXPERIMENTAL
Intervention: Low-dose dopamine
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 15
Study: 23722870

Group type: EXPERIMENTAL
Intervention: Oncogenetics training (4-hour session covering consultation skills, attitude, and clinical knowledge)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Oncogenetics training
Number of subjects: 88
Study: 22847178

Group type: EXPERIMENTAL
Intervention: SFA + LC n-3 PUFA
Number of subjects: 59

Group type: COMPARATOR
Intervention: SFA alone
Number of subjects: 59
Study: 19860512

Group type: EXPERIMENTAL
Intervention: Presurgical maxillary expansion (n = 64)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Standard protocol without presurgical maxillary expansion
Number of subjects: 198

Group type: COMPARATOR
Intervention: Patients treated by the highest volume operator
Number of subjects: 198

Group type: COMPARATOR
Intervention: Patients under 11 years of age
Number of subjects: 198

Group type: COMPARATOR
Intervention: Unilateral cleft lip and palate patients
Number of subjects: 198
Study: 17094088

Group type: EXPERIMENTAL
Intervention: Sarizotan 2 mg/day
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Sarizotan 10 mg/day
Number of subjects: 398

Group type: COMPARATOR
Intervention: Sarizotan (2, 4, or 10 mg/day)
Number of subjects: 398
Study: 15733882

Group type: EXPERIMENTAL
Intervention: 1-g oral dose of secnidazole (n=44)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 2-g oral dose of secnidazole (n=32)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both doses of secnidazole
Number of subjects: 80
Study: 11315503

Group type: EXPERIMENTAL
Intervention: Red palm oil (90 mg beta-carotene)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Beta-carotene supplements
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study: 9252738

Group type: EXPERIMENTAL
Intervention: Clobetasol propionate emollient 0.05 percent, 0.43 to 0.5 gm twice daily for four weeks
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Clobetasol propionate emollient 0.05 percent
Number of subjects: 47

Group type: COMPARATOR
Intervention: Emollient vehicle
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Clobetasol propionate emollient, 1.5 gm applied twice daily for seven consecutive days
Number of subjects: 47
Study: 8359085

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave lithotripsy
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 2891235

Group type: EXPERIMENTAL
Intervention: Hypoglycaemia induced between 3.00 and 4.00 h
Number of subjects: 7

Group type: COMPARATOR
Intervention: No hypoglycaemia
Number of subjects: 7
Study: 30220621

Group type: EXPERIMENTAL
Intervention: Laser groove treatment (100μm-deep, 150μm-deep, 200μm-deep)
Number of subjects: 230

Group type: COMPARATOR
Intervention: No-treatment
Number of subjects: 230

Group type: COMPARATOR
Intervention: Air abrasion treatment
Number of subjects: 230
Study: 28150850

Group type: EXPERIMENTAL
Intervention: Chewing 180 mg ticagrelor
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard oral 180 mg ticagrelor
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study: 26521576

Group type: EXPERIMENTAL
Intervention: Acupuncture-moxibustion
Number of subjects: 40

Group type: COMPARATOR
Intervention: Medication
Number of subjects: 40
Study: 24222836

Group type: EXPERIMENTAL
Intervention: Eptifibatide infusion <10 hours
Number of subjects: 3271

Group type: COMPARATOR
Intervention: Eptifibatide infusion 10-17 hours
Number of subjects: 3271

Group type: COMPARATOR
Intervention: Eptifibatide per-protocol infusion (18-24 hours)
Number of subjects: 3271
Study: 22186753

Group type: EXPERIMENTAL
Intervention: 30% hydrogen peroxide + sodium perborate paste (HP + SP)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 37% carbamide peroxide + sodium perborate paste (CP + SP)
Number of subjects: 20
Study: 19801812

Group type: EXPERIMENTAL
Intervention: Neurodynamic technique (NDT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 40
Study: 16440115

Group type: EXPERIMENTAL
Intervention: Rifampicin-based regimen
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ciprofloxacin-based regimen
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study: 15258349

Group type: COMPARATOR
Intervention: Aspirin (100-325 mg/d)
Number of subjects: 823

Group type: EXPERIMENTAL
Intervention: Ticlopidine (500 mg/d)
Number of subjects: 823

Group type: EXPERIMENTAL
Intervention: Clopidogrel (75 mg/d)
Number of subjects: 823
Study: 11419768

Group type: EXPERIMENTAL
Intervention: Diabetes recall system established at eight of the 21 sites, staff training in basic diabetes care, regular phone calls from the project officer, a two‐monthly newsletter and a mid‐project workshop.
Number of subjects: 678

Group type: EXPERIMENTAL
Intervention: Diabetes recall system established at eight of the 21 sites.
Number of subjects: 678
Study: 9438089

Group type: EXPERIMENTAL
Intervention: Saline containing a low dose of epinephrine (50 ml, diluted to 1:200,000) with drain clamping for 20 hours
Number of subjects: 283

Group type: COMPARATOR
Intervention: Saline only (50 ml) with drain clamping for 20 hours
Number of subjects: 283

Group type: COMPARATOR
Intervention: No drain-clamp method
Number of subjects: 283
Study: 8503807

Group type: EXPERIMENTAL
Intervention: Phenytoin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3435365

Group type: EXPERIMENTAL
Intervention: Ibuprofen 400mg tablet at the first sign of pain or bleeding, followed by 400mg every 4 to 6 hours for the duration of expected symptoms
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 28763401

Group type: EXPERIMENTAL
Intervention: Laser (L)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Estriol (E)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Laser + Estriol (LE)
Number of subjects: 45
Study: 26018670

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 52

Group type: COMPARATOR
Intervention: Midazolam-Fentanyl
Number of subjects: 52
Study: 26200403

Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Dabigatran
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control (Enoxaparin Monotherapy)
Number of subjects: 180
Study: 23306362

Group type: EXPERIMENTAL
Intervention: Prototype vaccine containing LCTBA and CFA/I overexpressing E. coli
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Prototype vaccine (higher dose)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Reference vaccine (CTB and inactivated wild type ETEC bacteria expressing CFA/I)
Number of subjects: 60
Study: 21688030

Group type: EXPERIMENTAL
Intervention: HHD group (4% succinylated gelatin infused at 20 ml•kg(‐1)BW•h(‐1) with targeted hematocrit of 30)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (conventional fluid replacement protocol)
Number of subjects: 16
Study: 17900579

Group type: EXPERIMENTAL
Intervention: 4 mg dexamethasone
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 8 mg dexamethasone
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 16615978

Group type: EXPERIMENTAL
Intervention: 1.25% povidone-iodine eyedrops
Number of subjects: 0

Group type: COMPARATOR
Intervention: 1% silver nitrate
Number of subjects: 0
Study: 12640221

Group type: EXPERIMENTAL
Intervention: Risperidone (0.5 mg/day, increased up to 2.0 mg/day based on response)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 10702163

Group type: EXPERIMENTAL
Intervention: Very-low-fat (VLF) diet (10% of energy from fat; 3% from saturated fat)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: High-unsaturated-fat (HUF) diet (32% of energy from fat; 6% from saturated fat)
Number of subjects: 62

Group type: COMPARATOR
Intervention: High-saturated-fat (HSF) diet (32% of energy from fat; 17% from saturated fat)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: All diets combined
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: High-fat diets (HSF and HUF)
Number of subjects: 62
Study: 7862905

Group type: EXPERIMENTAL
Intervention: Fluoxetine (n = 22)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Lofepramine (n = 18)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 73
Study: 2690098

Group type: EXPERIMENTAL
Intervention: 1-acetylcarnitine
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study: 1233188

Group type: EXPERIMENTAL
Intervention: Depot heparin (Calciparin)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (untreated patients)
Number of subjects: 65
Study: 28746244

Group type: EXPERIMENTAL
Intervention: Unicycling course (12 sessions)
Number of subjects: 20
Study: 31077214

Group type: EXPERIMENTAL
Intervention: Letrozole (group A)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control (group B)
Number of subjects: 130
Study: 25269569

Group type: EXPERIMENTAL
Intervention: CORE programme (30 minutes, five times per week for eight weeks, with hot-packs and transcutaneous electrical nerve stimulation)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: CORE programme
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (hot-packs and transcutaneous electrical nerve stimulation)
Number of subjects: 53
Study: 25458561

Group type: EXPERIMENTAL
Intervention: Diclazuril (1mg/kg BW)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Toltrazuril (15mg/kg BW)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Untreated control
Number of subjects: 199
Study: 22494866

Group type: EXPERIMENTAL
Intervention: PPCI with Postconditioning (PC)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Conventional PPCI
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: PPCI with Postconditioning (PC) after exclusion of diabetics
Number of subjects: 78
Study: 19398001

Group type: EXPERIMENTAL
Intervention: Anti-CD25 mAb induction (daclizumab)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Steroid therapy
Number of subjects: 15
Study: 17880476

Group type: EXPERIMENTAL
Intervention: Standardized protocol to maintain nasoenteral tube (NET) patency
Number of subjects: 60

Group type: COMPARATOR
Intervention: Historical control (baseline data)
Number of subjects: 60
Study: 15105387

Group type: EXPERIMENTAL
Intervention: Electro-acupuncture (EA) in combination with a paracervical block (PCB) (n = 100)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional medical analgesia (CMA) in combination with a PCB (n = 100)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Electro-acupuncture (EA)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional medical analgesia (CMA)
Number of subjects: 200
Study: 11706930

Group type: EXPERIMENTAL
Intervention: Internet search using the search strategy 'study methodology NEAR intervention NEAR condition' on AltaVista
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Internet search for published studies
Number of subjects: 429
Study: 9642019

Group type: EXPERIMENTAL
Intervention: Alzheimer's disease patients
Number of subjects: 2

Group type: COMPARATOR
Intervention: Healthy elderly controls
Number of subjects: 2
Study: 7717792

Group type: EXPERIMENTAL
Intervention: Structured sleep hygiene with early morning light therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Structured sleep hygiene
Number of subjects: 30

Group type: COMPARATOR
Intervention: Structured sleep hygiene with late afternoon moderate exercise
Number of subjects: 30
Study: 1781822

Group type: EXPERIMENTAL
Intervention: Nonionic agents (ioxaglate, iohexol)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ionic agent (Renografin‐76)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ioxaglate
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Iohexol
Number of subjects: 100
Study: 7293938

Group type: EXPERIMENTAL
Intervention: Garlic (for 10 months)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Garlic (for 6 months)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control (Group B2)
Number of subjects: 82
Study: 30513395

Group type: EXPERIMENTAL
Intervention: fMRI-Neurofeedback of right inferior frontal cortex (rIFC)
Number of subjects: 18
Study: 29061627

Group type: EXPERIMENTAL
Intervention: Consultations and the use of the Jourvie Research app
Number of subjects: 30

Group type: COMPARATOR
Intervention: Consultations only
Number of subjects: 30
Study: 26510725

Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg daily
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Esomeprazole
Number of subjects: 120
Study: 24153331

Group type: COMPARATOR
Intervention: Intervention (not specified in detail, but implied to be treatment for JCCP)
Number of subjects: 0
Study: 21425274

Group type: EXPERIMENTAL
Intervention: Color Doppler ultrasound (CDUS)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Computed Tomographic Angiography (CTA)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Comparison of aneurysm diameter measurement
Number of subjects: 29
Study: 19641980

Group type: EXPERIMENTAL
Intervention: Fentanyl 0.6 microg x kg(‐1) and midazolam 9 microg x kg(‐1) premedication (Group FM)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Normal saline placebo (Group PLAC)
Number of subjects: 80
Study: 17823740

Group type: EXPERIMENTAL
Intervention: Oesophageal Doppler (OD)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Thermodilution (TD)
Number of subjects: 10
Study: 15234049

Group type: EXPERIMENTAL
Intervention: Beta-irradiation (beta-RT) with (90)Sr, delivered 2500 cGy to the sclera surface at a dose rate of 200-250 cGy/min
Number of subjects: 91

Group type: COMPARATOR
Intervention: Sham RT (control group), using the same type of applicator without the (90)Sr layer
Number of subjects: 91
Study: 11548898

Group type: EXPERIMENTAL
Intervention: Chronic sinusitis group (patients undergoing transnasal sinus operation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (patients undergoing septoplasty)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 11398306

Group type: EXPERIMENTAL
Intervention: 600 micrograms misoprostol
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 8283895

Group type: EXPERIMENTAL
Intervention: Reperfusion pressure of 50 mm Hg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Reperfusion pressure of 75 mm Hg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups (50 mm Hg and 75 mm Hg)
Number of subjects: 60
Study: 2902671

Group type: EXPERIMENTAL
Intervention: broxaterol (0.5 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: procaterol (0.05 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study: 31190608

Group type: EXPERIMENTAL
Intervention: three-stage venous cannula (3S)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: three-stage venous cannula with additional 'fenestrated' ridges (F3S)
Number of subjects: 48

Group type: COMPARATOR
Intervention: conventional two-stage (2S)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: three-stage cannula (3S)
Number of subjects: 48
Study: 28393317

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) intervention
Number of subjects: 52

Group type: COMPARATOR
Intervention: MS medication video (attention control)
Number of subjects: 52
Study: 26224613

Group type: EXPERIMENTAL
Intervention: Autologous conditioned plasma (ACP) injections
Number of subjects: 99

Group type: COMPARATOR
Intervention: Betamethasone injections
Number of subjects: 99
Study: 21812820

Group type: EXPERIMENTAL
Intervention: 4 × 8 min training
Number of subjects: 35

Group type: COMPARATOR
Intervention: Low only (n=8)
Number of subjects: 35

Group type: COMPARATOR
Intervention: 4 × 16 min
Number of subjects: 35

Group type: COMPARATOR
Intervention: 4 × 4 min
Number of subjects: 35
Study: 21402616

Group type: EXPERIMENTAL
Intervention: lesogaberan (65 mg twice daily)
Number of subjects: 244

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: lesogaberan
Number of subjects: 244
Study: 18504447

Group type: EXPERIMENTAL
Intervention: High-flavanol cocoa (HF, 902 mg flavanols)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Regular exercise (3 x 45 min per week at 75% of age-predicted maximum heart rate)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Low-flavanol cocoa (LF, 36 mg flavanols)
Number of subjects: 49
Study: 17038680

Group type: EXPERIMENTAL
Intervention: Primaquine 45 mg total dose (15 mg/day)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Primaquine 105 mg total dose (15 mg/day)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Primaquine 210 mg total dose (15 mg/day)
Number of subjects: 210
Study: 12707160

Group type: EXPERIMENTAL
Intervention: 75% N(2)O
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (0% N(2)O)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: N(2)O (all concentrations: 25%, 50%, 75%)
Number of subjects: 100
Study: 10767583

Group type: EXPERIMENTAL
Intervention: Rivastigmine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 9363045

Group type: EXPERIMENTAL
Intervention: Low-dosage abecarnil (3.0-7.0 mg daily)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: High-dosage abecarnil (7.5-17.5 mg daily)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 182